Literature DB >> 30714620

Effect of vitamin K administration on rate of warfarin reversal.

Nick B Polito1, Eric Kanouse1, Courtney M C Jones2, Molly McCann3, Majed A Refaai4, Nicole M Acquisto5.   

Abstract

BACKGROUND: Vitamin K is reported to begin reversing warfarin within 6 to 12 hours, but this may occur sooner. We sought to determine the rate of international normalized ratio (INR) reversal following vitamin K and relationships with dose, route, and baseline INR.
METHODS: We evaluated adult patients receiving vitamin K monotherapy for warfarin reversal. Post-vitamin K INRs through 48 hours were collected. Relationships between vitamin K dose and route and baseline INR on rate of reversal and complete reversal (INR < 1.5) were evaluated. Assessment was performed graphically using scatter plots with a line of best fit and a counting process model to determine variables associated with achieving complete reversal.
RESULTS: A total of 469 post-vitamin K INRs from 235 patients were included. Time to first INR follow-up after vitamin K administration averaged 10.5 ± 4.2 hours. A significant decrease was detected in INR values in comparison to the baseline INR (3.0 ± 1.9 vs. 4.7 ± 2.2; p < 0.01). Rapid and steady INR change began immediately after vitamin K administration (0-4 hr). A high vitamin K dose and intravenous route were associated with rapid INR change and complete reversal (Vitamin K 10 mg [hazard ratio, 2.4; 95% confidence interval, 1.4-4.2] and IV route [hazard ratio, 1.8; 95% confidence interval, 1.3-2.6]); however, overall complete reversal at 24 and 48 hours was low (14.5% and 41.7%, respectively). Higher baseline INR was associated with rapid INR change and lower baseline INR with complete reversal.
CONCLUSION: Vitamin K alone starts to reverse warfarin immediately. High vitamin K doses and intravenous route are associated with faster INR reversal. Baseline INR also influences rate of correction and frequency of achieving complete reversal.
© 2019 AABB.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30714620     DOI: 10.1111/trf.15146

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  4 in total

Review 1.  Blood Banking and Transfusion Medicine Challenges During the COVID-19 Pandemic.

Authors:  Andy Ngo; Debra Masel; Christine Cahill; Neil Blumberg; Majed A Refaai
Journal:  Clin Lab Med       Date:  2020-08-08       Impact factor: 1.935

2.  Unintentional ingestion of a high dose of acenocoumarol in a young child.

Authors:  Martijn R Brands; Jelmer Sytema; Marinus van Hulst; Arvid Wa Kamps
Journal:  BMJ Case Rep       Date:  2021-04-01

3.  Novel Anticoagulants and Hip Fractures in the Elderly.

Authors:  George Matheron; Imani Looby; Mehdi Khan; Muhammad A Fazal
Journal:  Cureus       Date:  2022-03-10

4.  Successful intravenous thrombolysis in an acute ischemic stroke patient with contraindicating values of the international standardized ratio and prothrombin time.

Authors:  Liming Cao; Xibao Tong; Hua Lu
Journal:  Acta Neurol Belg       Date:  2020-10-09       Impact factor: 2.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.